HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Disease of liver — Clinical Guidelines

Overview

Liver diseases encompass a broad spectrum of conditions affecting liver function, including metabolic disorders, genetic defects impacting organelle function, and structural abnormalities leading to hepatopathy. These conditions can manifest with hepatic dysfunction, developmental delays, and systemic manifestations such as cardiomyopathy and sensory impairments. 2 3 5

Diagnosis

Clinical Presentation: Developmental delay, intellectual disability, sensorineural deafness, retinitis pigmentosa, hepatomegaly, and biochemical markers like elevated VLCFAs and BCFAs. 3 5

Biochemical Tests: Elevated plasma levels of very-long-chain fatty acids (VLCFAs) and branched-chain fatty acids (BCFAs) indicative of peroxisomal dysfunction. 3 5

Fibroblast Analysis: Deficiency in multiple peroxisomal enzyme activities and absence or reduced number of peroxisomes. 3 5

Genetic Testing: Identification of specific gene mutations (e.g., NAA10, PEX6) associated with the disorder. 2 3

Management

Supportive Care: Management of symptoms including developmental support, hearing aids, and multidisciplinary care teams. 3

Nutritional Support: Tailored nutritional interventions to address metabolic deficiencies, though specific drug treatments are limited. 5

Monitoring: Regular assessment of liver function, growth parameters, and neurological development. 3 5

Special Populations

Pediatrics: Developmental delays and intellectual disabilities require early intervention programs and continuous monitoring. 2 3

Comorbidities: Peroxisomal disorders often coexist with cardiac abnormalities necessitating cardiological surveillance. 2 3

Key Recommendations

Genetic Counseling and Early Diagnosis: Offer genetic counseling and early diagnostic testing for peroxisomal disorders in families with a history of developmental delay and metabolic abnormalities. (Evidence: Moderate 3 5)

Comprehensive Multidisciplinary Care: Implement a multidisciplinary approach including pediatricians, neurologists, hepatologists, and geneticists to manage the diverse symptoms. (Evidence: Expert opinion 3)

Regular Monitoring of Biomarkers: Regularly monitor plasma VLCFAs and BCFAs in affected individuals and their parents for early detection of peroxisomal dysfunction. (Evidence: Moderate 3 5)

References

1 Zhu Z, Cheng Y, Zeng L, Elhoumed M, He G, Li W et al.. Association of Antenatal Micronutrient Supplementation With Adolescent Intellectual Development in Rural Western China: 14-Year Follow-up From a Randomized Clinical Trial. JAMA pediatrics 2018. link 2 Støve SI, Blenski M, Stray-Pedersen A, Wierenga KJ, Jhangiani SN, Akdemir ZC et al.. A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy. European journal of human genetics : EJHG 2018. link 3 Raas-Rothschild A, Wanders RJ, Mooijer PA, Gootjes J, Waterham HR, Gutman A et al.. A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parents. American journal of human genetics 2002. link 4 . Urea excretion in white rats and kangaroo rats as influenced by excitement and by diet. Journal of the American Society of Nephrology : JASN 2001. link 5 Wanders RJ, Schutgens RB, Schrakamp G, Tager JM, Van den Bosch H, Moser AB et al.. Neonatal adrenoleukodystrophy. Impaired plasmalogen biosynthesis and peroxisomal beta-oxidation due to a deficiency of catalase-containing particles (peroxisomes) in cultured skin fibroblasts. Journal of the neurological sciences 1987. link90132-8) 6 Hill JE, Burke DL, Rowland GN. Hepatopathy and lymphosarcoma in a mynah bird with excessive iron storage. Avian diseases 1986. link 7 Takahashi T, Nakada H, Okumura T, Sawamura T, Tashiro Y. Phosphorylation of the rat hepatocyte asialoglycoprotein receptor. Biochemical and biophysical research communications 1985. link90292-x)

Disease of liver